Literature DB >> 10858413

A European view on the North American fifth consensus on antithrombotic therapy.

M Verstraete1, C R Prentice, M Samama, R Verhaeghe.   

Abstract

An American-Canadian group of experts have, in the November 1998 issue of CHEST, published for the fifth time their recommendations for antithrombotic therapy. This remarkable consensus document was the result of an extensive review of the literature by an interdisciplinary group. Considering the impact of this document on medical practice, also outside North America, a group of European experts reviewed in detail the fifth report, particularly the sections on clinical indications of antithrombotic treatment. The aim was not to indicate the many areas of agreement and to quote literature that has become available since publication of the last consensus documents, but rather to refer to the gray zones of uncertainty and limited number of divergent opinions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10858413     DOI: 10.1378/chest.117.6.1755

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  6 in total

1.  [Heart diseases in pregnancy].

Authors:  Vera Regitz-Zagrosek; Christa Gohlke-Bärwolf; Annette Geibel-Zehender; Markus Haass; Harald Kaemmerer; Irmtraut Kruck; Christoph Nienaber
Journal:  Clin Res Cardiol       Date:  2008-09       Impact factor: 5.460

2.  Long term complications of inferior vena cava thrombosis.

Authors:  M Häusler; D Hübner; T Delhaas; E G Mühler
Journal:  Arch Dis Child       Date:  2001-09       Impact factor: 3.791

Review 3.  The effect of factor V Leiden carriage on maternal and fetal health.

Authors:  Dena Bloomenthal; Peter von Dadelszen; Robert Liston; Laura Magee; Peter Tsang
Journal:  CMAJ       Date:  2002-07-09       Impact factor: 8.262

4.  Multiplex assay for genetic testing of thrombophilia: a method for routine clinical care.

Authors:  Mónica López; Pilar Giraldo; Patricia Alvarez; R Cornudella; Miguel Pocoví; Antonio Martínez; Jordi Fontcuberta; José Manuel Soria
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

Review 5.  Enoxaparin: an update of its clinical use in the management of acute coronary syndromes.

Authors:  Tim Ibbotson; Karen L Goa
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 6.  Evidence Gaps in the Era of Non-Vitamin K Oral Anticoagulants.

Authors:  Konstantinos N Aronis; Elaine M Hylek
Journal:  J Am Heart Assoc       Date:  2018-01-26       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.